Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVax-3: FluMist vs IIV Immune Response
NCT07177417Phase 4Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza, sponsored by Washington University School of Medicine. Started Sep 2025; status: recruiting.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07177417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07177417.